Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of CD33CAR modified high affinity NK cells (t-haNK) to reduce myeloid-derived suppressor cells suppressor activity (or reduce negative impact on NK cell activity)

Use of CD33CAR modified high affinity NK cells (t-haNK) to reduce myeloid-derived suppressor cells suppressor activity (or reduce negative impact on NK cell activity)

US Patent 12403178 · Granted Sep 2, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and systems for separating metals2025
Curation and provision of digital content2025
Distributed command execution in multi-location studio environments2025
Location indexed blockchains, systems and method2025
Distributed storage systems and methods2025
Combined invasion and cytotoxicity assay using chemokine secreting target cells2025
Combined invasion and cytotoxicity assay using chemokine secreting target cells2025
Latency management in an event driven gaming network2025
Fine grained network management to edge device features2025
Maximizing T-cell memory and compositions and methods therefor2025
Modified NK-92 haNK003 cells for the clinic2025
Modified NK-92 haNK003 cells for the clinic2025